Sharifi, N., Kim, H., Alyamani, M., Diaz, R., Beltran, H., Armstrong, A. J., Morris, M. J., Halabi, S., Ryan, C. J. (2025). Adrenal androgens and overall survival (OS) in men with castration-resistant prostate cancer (CRPC) treated with enzalutamide without (ENZ) or with abiraterone and prednisone (ENZ/AAP) (Alliance).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.230